Don't miss this webinar on the combination of immunotherapy and radiotherapy!
Immerse yourself in the latest advancements in the field as we delve into the most recent concepts about immunotherapy radiotherapy combinations.
cassyni.com/events/KySysPvEn…
Ready for #immunorad2023 Sept 27-29? Our 7th edition on #immunotherapy and #radiotherapy includes an exciting program of clinical research presentations, medical education activities, abstract & poster sessions. To view the program & register, visit: immunorad.org
I am pleased to host this 7th edition international event which includes a team of world-renowned speakers who will present current advancements at the intersection between radiation therapy and anti-tumor immune responses.
immunorad.org#immunorad2023#immunotherapy
Blocking a key immune protein improves radiation therapy for cancer | Biological Sciences Division | The University of Chicago biologicalsciences.uchicago.…
And that's a wrap! To all our organizers, speakers, sponsors & participants, THANK YOU for making the #ImmunoRad21 Conference in Paris a huge success! See you next year in New York! Sept 22-24, 2022 #radonc#immunology#radiotherapy#oncology
Today we kick off #ImmunoRad21 ! A warm welcome to our speakers, poster presenters, delegates, sponsors, media and educational partners – looking forward to seeing you all!! #radonc#immunology#radiotherapy#oncology
Attending #ImmunoRad21 in Paris? Join us for our in-person poster sessions taking place on Tuesday, Sept 14, and Thursday Sept 16, from 6 PM to 8:30 PM CEST. Ample opportunity to network and engage with peers. #radonc#immunotherapy#radiotherapy#oncology
Looking forward to welcoming our esteemed colleagues over 4 days IRL at #ImmunoRad21 in Paris on September 14-17 at @CRCordeliers
We have gathered a unique panel of speakers and look forward to innovative presentations and enriching discussions.
#immunotherapy#radiotherapy#onco
Low doses of radiation therapy increase the immunosuppressive profile of lung macrophages via IL-10 production and IFNγ/IL-6 suppression: a therapeutic strategy to counteract lung inflammation? biorxiv.org/content/10.1101/…
Molecular radiotherapy and innovative therapeutics INSERM1030 unit , kick starter meeting for the new 5 years contract. @Gustaveroussy@inserm @université-paris-saclay
Digital medicine approved in France for lung cancer surveillance. Dr Fabrice Dénis présents his web and phone app at our weekly department round form the theory of chaos to a JAMA paper ...and reimbursement ..
A Post-doctoral position in Tumor Immunology is available in the Molecular Radiotherapy INSERM U1030 unit at Gustave Roussy Cancer Campus, Paris. One post-doctoral position will be available to study combination of radiotherapy with immunotherapy strategies perfettini@orange.fr
Physicien médical Gustave Roussy, recherche Physicien Médical (H/F).
Il intègrera une équipe composée de 11 physiciens en radiothérapie-curiethérapie, 4 techniciens de contrôle de qualité, 11 dosimétristes et un chef du service de physique.